BRAF GENE MUTATIONS AND PROGNOSTIC SIGNIFICANCE OF CLINICAL FINDINGS IN CASTLEMAN DISEASE
dc.authorid | yilmaz, mustafa/0000-0002-1723-9726 | |
dc.authorid | AKPOLAT, Nusret/0000-0002-9138-2117 | |
dc.authorid | demir, cengiz/0000-0001-9856-184X | |
dc.authorid | Keklik, Muzaffer/0000-0002-6426-5249; | |
dc.authorwosid | yilmaz, mustafa/AAA-7090-2020 | |
dc.authorwosid | AKPOLAT, Nusret/ABF-6986-2020 | |
dc.authorwosid | demir, cengiz/JZE-3811-2024 | |
dc.authorwosid | Keklik, Muzaffer/B-3037-2016 | |
dc.authorwosid | kocarslan, sezen/JBR-8568-2023 | |
dc.authorwosid | kocarslan, sezen/AAR-6461-2020 | |
dc.authorwosid | Saydam, Guray/W-3827-2017 | |
dc.contributor.author | Turker, M. | |
dc.contributor.author | Subari, S. | |
dc.contributor.author | Keklik, M. | |
dc.contributor.author | Dal, M. S. | |
dc.contributor.author | Sahin, N. | |
dc.contributor.author | Comert, M. | |
dc.contributor.author | Alanoglu, G. | |
dc.date.accessioned | 2024-08-04T20:57:18Z | |
dc.date.available | 2024-08-04T20:57:18Z | |
dc.date.issued | 2016 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description | 21st Congress of the European-Hematology-Association -- JUN 09-12, 2016 -- Copenhagen, DENMARK | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | European Hematol Assoc | en_US |
dc.identifier.endpage | 760 | en_US |
dc.identifier.issn | 0390-6078 | |
dc.identifier.startpage | 759 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/102500 | |
dc.identifier.volume | 101 | en_US |
dc.identifier.wos | WOS:000379484603023 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Ferrata Storti Foundation | en_US |
dc.relation.ispartof | Haematologica | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keywords] | en_US |
dc.title | BRAF GENE MUTATIONS AND PROGNOSTIC SIGNIFICANCE OF CLINICAL FINDINGS IN CASTLEMAN DISEASE | en_US |
dc.type | Conference Object | en_US |